519 studies found for:    (pregnancy OR maternal) AND hiv
Show Display Options
Rank Status Study
1 Active, not recruiting Maternal/Infant Peripartum NVP, Versus Infant Only Peripartum NVP, or Maternal LPV/r in Addition to Standard ZDV Prophylaxis for the Prevention of Perinatal (PMTCT) HIV in Thailand
Conditions: HIV Infections;   Pregnancy
Interventions: Drug: Maternal and infant nevirapine;   Drug: Maternal placebo and infant nevirapine;   Drug: Maternal lopinavir+ritonavir;   Drug: zidovudine
2 Completed
Has Results
HSV-2 Suppression to Reduce Maternal HIV-1 RNA Levels During Pregnancy and Breastfeeding
Conditions: HIV Infections;   Herpes Simplex
Interventions: Drug: valacyclovir;   Drug: placebo
3 Recruiting Evaluating Strategies to Reduce Mother-to-Child Transmission of HIV Infection in Populations Using Formula Feeding (PROMISE)
Condition: HIV
Interventions: Drug: Zidovudine (ZDV);   Drug: Nevirapine (NVP);   Drug: Emtricitabine-tenofovir disoproxil fumarate (Truvada [TRV]);   Drug: Lamivudine-Zidovudine (3TC-ZDV);   Drug: Lopinavir-ritonavir (LPV-RTV)
4 Recruiting Evaluating Strategies to Reduce Mother-to-Child Transmission of HIV Infection in Resource-Limited Countries
Condition: HIV Infections
Interventions: Drug: Zidovudine (ZDV);   Drug: Nevirapine (NVP);   Drug: Emtricitabine-tenofovir disoproxil fumarate (Truvada [TRV]);   Drug: Lamivudine-Zidovudine (3TC-ZDV);   Drug: Lopinavir-ritonavir (LPV-RTV)
5 Recruiting Safety Study of a Tenofovir-containing Drug Regimen for the Prevention of Mother-to-child Transmission of HIV and HBV
Conditions: HIV;   Hepatitis B
Interventions: Drug: Tenofovir/lamivudine/lopinavir-ritonavir;   Drug: Zidovudine/lamivudine/lopinavir-ritonavir
6 Recruiting Evaluating the Response to Three Antiretroviral Medication Regimens in HIV-Infected Pregnant Women, Who Begin Antiretroviral Therapy Between 28 and 36 Weeks of Pregnancy, for the Prevention of Mother-to-Child Transmission
Condition: HIV Infections
Interventions: Drug: Lamivudine/zidovudine;   Drug: Lopinavir/ritonavir;   Drug: Efavirenz;   Drug: Raltegravir
7 Completed Nevirapine Study for the Prevention of Maternal-Infant HIV Transmission in Uganda
Condition: HIV Infections
Interventions: Drug: Nevirapine;   Drug: HIV immune globulin solution
8 Completed Influence of Chloroquine on HIV Viral Load Among Pregnant Women in Uganda
Conditions: Malaria in Pregnancy;   HIV Infections
Interventions: Drug: sulfadoxine-pyrimethamine intermittent preventive treatment;   Drug: chloroquine
9 Completed A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum Globulin (HIVIG) for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine (AZT)
Conditions: HIV Infections;   Pregnancy
Interventions: Drug: Anti-HIV Immune Serum Globulin (Human);   Drug: Globulin, Immune;   Drug: Zidovudine
10 Completed Shortened Zidovudine Regimens to Prevent Mother-to-Child Transmission of HIV Type 1
Conditions: HIV Infections;   Pregnancy
Interventions: Drug: ZDV Short (mother)-Short (infant): Comparison of zidovudine durations;   Drug: ZDV Short (mother)-Long (infant): Comparison of zidovudine durations;   Drug: ZDV Long (mother)-Short (infant): Comparison of zidovudine durations;   Drug: ZDV Long (mother)-Long (infant): Comparison of zidovudine durations
11 Recruiting Perinatal Antiretroviral Intensification for PMTCT of HIV in Late Comers
Condition: HIV Infections
Intervention: Drug: Nevirapine, zidovudine, lamivudine
12 Not yet recruiting Antiretroviral Regimens Containing Raltegravir for Prophylaxis of Mother-to-child-transmission of HIV Infection
Conditions: HIV;   Pregnancy
Interventions: Drug: Raltegravir;   Drug: Lopinavir/Ritonavir
13 Completed Fortovase (Saquinavir) Given With Low-Dose Ritonavir, Zidovudine, and Lamivudine to HIV-Positive Pregnant Women During and After Pregnancy and to Their Newborns
Conditions: HIV Infections;   Pregnancy
Interventions: Drug: Ritonavir;   Drug: Saquinavir;   Drug: Lamivudine;   Drug: Zidovudine
14 Completed A Study of Nevirapine to Prevent HIV Transmission From Mothers to Their Infants
Conditions: HIV Infections;   Pregnancy
Intervention: Drug: Nevirapine
15 Completed A Study of Nevirapine for the Prevention of HIV Transmission From Mothers to Their Babies
Conditions: HIV Infections;   Pregnancy
Intervention: Drug: Nevirapine
16 Completed Combination Treatment With and Without Protease Inhibitors for Women Who Begin Therapy for HIV Infection During Pregnancy
Conditions: HIV Infections;   Pregnancy
Interventions: Drug: Lamivudine;   Drug: Lamivudine/Zidovudine;   Drug: Nelfinavir mesylate;   Drug: Nevirapine;   Drug: Zidovudine
17 Unknown  Clinical Study of an Aluvia-based HAART Regimen for Prevention of Mother-to-child HIV Transmission in Africa
Condition: HIV
Intervention: Drug: Lopinavir/Ritonavir (200/50 mg) Tablets + Zidovudine + 3TC
18 Completed Mentor Mothers: A Sustainable Family Intervention in South African Townships
Conditions: Human Immunodeficiency Virus;   Acquired Immune Deficiency Syndrome;   Tuberculosis
Intervention: Behavioral: Peer support and mentoring
19 Active, not recruiting Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission
Conditions: HIV Infections;   Pregnancy Complications, Infectious
Intervention: Behavioral: Adherence assessment
20 Completed A Study of Nevirapine to Prevent HIV Transmission From Mothers to Their Babies
Conditions: HIV Infections;   Pregnancy
Intervention: Drug: Nevirapine

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years